Comparing the Keyto App and Device with Weight Watchers' WW App for Weight Loss: Protocol for a Randomized Trial

Sean R Locke, Kaja Falkenhain, Dylan A Lowe, Terry Lee, Joel Singer, Ethan J Weiss, Jonathan P Little, Sean R Locke, Kaja Falkenhain, Dylan A Lowe, Terry Lee, Joel Singer, Ethan J Weiss, Jonathan P Little

Abstract

Background: Obesity and being overweight are major contributing factors for many diseases. Calorie restricted diets often fail to result in sustained long-term weight loss. Very low-carbohydrate, high-fat ketogenic diets have been suggested to have superior metabolic and weight loss effects. Keyto is a low-cost, highly scalable mobile health (mHealth) app paired with a noninvasive biofeedback tool aimed at facilitating weight loss through a personalized healthy and predominantly plant- and fish-based ketogenic diet.

Objective: This protocol describes a randomized trial comparing the efficacy of the Keyto mHealth app and device intervention to that of Weight Watchers' WW app in individuals who are overweight or obese. The primary outcome is weight loss after 12 weeks. Secondary and exploratory outcomes, including metabolic and cardiovascular risk factors, will be assessed at 12, 24, and 48 weeks.

Methods: A total of 144 participants will be recruited and randomized to either the Keyto program or Weight Watchers program. Study participants will be guided through the study via video conference or phone calls and will undergo a fasting blood analysis performed by a third-party diagnostic lab at weeks 0 and 12 to assess metabolic and cardiovascular risk markers. All participants will be asked to weigh themselves daily on a study-provided Bluetooth-enabled scale. Participants randomized to the Keyto arm will also be asked to measure their breath acetone levels, a measure of ketosis, with the Keyto device 3 times per day.

Results: Recruitment started in December 2019. Rolling recruitment is expected to be completed by July 2020. Data collection and analysis of the primary intervention phase is expected to be completed in October 2020. The 24- and 48-week follow-ups are expected to be completed in January 2021 and July 2021, respectively.

Conclusions: This trial will provide high-quality evidence regarding the efficacy of the Keyto weight loss program in individuals who are overweight and obese in a free-living condition. This study also fills a gap by examining the impact of a ketogenic diet emphasizing plant- and fish-based fats on blood lipid profile and cardiovascular disease risk.

Trial registration: ClinicalTrials.gov NCT04165707; https://ichgcp.net/clinical-trials-registry/NCT04165707.

International registered report identifier (irrid): DERR1-10.2196/19053.

Keywords: diet; ketogenic diet; low carbohydrate; mHealth; weight loss.

Conflict of interest statement

Conflicts of Interest: JPL is chief scientific officer for the Institute for Personalized Therapeutic Nutrition, a not-for-profit organization promoting a food-first approach to treating and preventing chronic disease. JPL holds shares in Metabolic Insights Inc, a for-profit company developing a saliva insulin monitor. EJW is an equity holder at Keyto and Virta Health. DAL is employed as a consultant for Keyto. All other authors have no conflicts to declare.

©Sean R Locke, Kaja Falkenhain, Dylan A Lowe, Terry Lee, Joel Singer, Ethan J Weiss, Jonathan P Little. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 17.08.2020.

References

    1. Pi-Sunyer X. The medical risks of obesity. Postgrad Med. 2009 Nov;121(6):21–33. doi: 10.3810/pgm.2009.11.2074.
    1. Santos I, Sniehotta F, Marques M, Carraça E V, Teixeira P J. Prevalence of personal weight control attempts in adults: a systematic review and meta-analysis. Obes Rev. 2017 Jan;18(1):32–50. doi: 10.1111/obr.12466.
    1. Anderson J, Konz E, Frederich R, Wood C. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr. 2001 Nov;74(5):579–84. doi: 10.1093/ajcn/74.5.579.
    1. Andreyeva T, Long M, Henderson K, Grode G. Trying to lose weight: diet strategies among Americans with overweight or obesity in 1996 and 2003. J Am Diet Assoc. 2010 Apr;110(4):535–42. doi: 10.1016/j.jada.2009.12.029.
    1. Westman E, Tondt J, Maguire E, Yancy W. Implementing a low-carbohydrate, ketogenic diet to manage type 2 diabetes mellitus. Expert Rev Endocrinol Metab. 2018 Sep;13(5):263–272. doi: 10.1080/17446651.2018.1523713.
    1. van Zuuren Esther J, Fedorowicz Z, Kuijpers T, Pijl H. Effects of low-carbohydrate- compared with low-fat-diet interventions on metabolic control in people with type 2 diabetes: a systematic review including GRADE assessments. Am J Clin Nutr. 2018 Aug 01;108(2):300–331. doi: 10.1093/ajcn/nqy096.
    1. Tobias D, Chen M, Manson J, Ludwig D, Willett W, Hu F. Effect of low-fat diet interventions versus other diet interventions on long-term weight change in adults: a systematic review and meta-analysis. The Lancet Diabetes & Endocrinology. 2015 Dec;3(12):968–979. doi: 10.1016/s2213-8587(15)00367-8.
    1. Paoli A, Rubini A, Volek J, Grimaldi K. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr. 2013 Aug;67(8):789–96. doi: 10.1038/ejcn.2013.116.
    1. Bueno N, de Melo Isv, de Oliveira Sl, da Rocha Ataide T. Very-low-carbohydrate ketogenic diet low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. Br J Nutr. 2013 May 07;110(7):1178–1187. doi: 10.1017/s0007114513000548.
    1. Triffoni-Melo Andresa de Toledo, Dick-de-Paula I, Portari G, Jordao A, Garcia Chiarello Paula, Diez-Garcia R. Short-term carbohydrate-restricted diet for weight loss in severely obese women. Obes Surg. 2011 Aug;21(8):1194–202. doi: 10.1007/s11695-010-0110-6.
    1. Gibson A, Seimon RV, Lee C M Y, Ayre J, Franklin J, Markovic T P, Caterson I D, Sainsbury A. Do ketogenic diets really suppress appetite? A systematic review and meta-analysis. Obes Rev. 2015 Jan;16(1):64–76. doi: 10.1111/obr.12230.
    1. Deemer S, Plaisance E, Martins C. Impact of ketosis on appetite regulation-a review. Nutr Res. 2020 May;77:1–11. doi: 10.1016/j.nutres.2020.02.010.
    1. Ebbeling C, Feldman H, Klein G, Wong J, Bielak L, Steltz Sarah K, Luoto Patricia K, Wolfe Robert R, Wong William W, Ludwig David S. Effects of a low carbohydrate diet on energy expenditure during weight loss maintenance: randomized trial. BMJ. 2018 Nov 14;363:k4583. doi: 10.1136/bmj.k4583.
    1. Flores Mateo Gemma, Granado-Font E, Ferré-Grau Carme, Montaña-Carreras Xavier. Mobile Phone Apps to Promote Weight Loss and Increase Physical Activity: A Systematic Review and Meta-Analysis. J Med Internet Res. 2015 Nov 10;17(11):e253. doi: 10.2196/jmir.4836.
    1. Burke L, Wang J, Sevick M. Self-monitoring in weight loss: a systematic review of the literature. J Am Diet Assoc. 2011 Jan;111(1):92–102. doi: 10.1016/j.jada.2010.10.008.
    1. Foster G, Wyatt H, Hill J, McGuckin B, Brill C, Mohammed Bs, Szapary Po, Rader Dj, Edman Js, Klein S. A Randomized Trial of a Low-Carbohydrate Diet for Obesity. N Engl J Med. 2003 May 22;348(21):2082–2090. doi: 10.1056/nejmoa022207.
    1. Nielsen J, Gando C, Joensson E, Paulsson C. Low carbohydrate diet in type 1 diabetes, long-term improvement and adherence: A clinical audit. Diabetol Metab Syndr. 2012 May 31;4(1):23. doi: 10.1186/1758-5996-4-23.
    1. Anderson J. Measuring breath acetone for monitoring fat loss: Review. Obesity (Silver Spring) 2015 Dec;23(12):2327–34. doi: 10.1002/oby.21242. doi: 10.1002/oby.21242.
    1. Kirkpatrick CF, Bolick JP, Kris-Etherton PM, Sikand G, Aspry KE, Soffer DE, Willard K, Maki KC. Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: A scientific statement from the National Lipid Association Nutrition and Lifestyle Task Force. J Clin Lipidol. 2019;13(5):689–711.e1. doi: 10.1016/j.jacl.2019.08.003.
    1. Gudzune K, Doshi R, Mehta A, Chaudhry Z, Jacobs D, Vakil Rm, Lee Cj, Bleich Sn, Clark Jm. Efficacy of Commercial Weight-Loss Programs. Ann Intern Med. 2015 Apr 07;162(7):501. doi: 10.7326/m14-2238.
    1. Breton E, Fuemmeler B, Abroms L. Weight loss-there is an app for that! But does it adhere to evidence-informed practices? Transl Behav Med. 2011 Dec;1(4):523–9. doi: 10.1007/s13142-011-0076-5.
    1. World Health Organization Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance. World Health Organization. 2020. Jul 14, [2020-03-13]. .
    1. Must A, Spadano J, Coakley E H, Field A E, Colditz G, Dietz W H. The disease burden associated with overweight and obesity. JAMA. 1999 Oct 27;282(16):1523–9. doi: 10.1001/jama.282.16.1523.
    1. DiNicolantonio J, O'Keefe James H. Effects of dietary fats on blood lipids: a review of direct comparison trials. Open Heart. 2018;5(2):e000871. doi: 10.1136/openhrt-2018-000871.
    1. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010 Mar 23;7(3):e1000252. doi: 10.1371/journal.pmed.1000252.
    1. Subar AF, Kirkpatrick SI, Mittl B, Zimmerman TP, Thompson FE, Bingley C, Willis G, Islam NG, Baranowski T, McNutt S, Potischman N. The Automated Self-Administered 24-hour dietary recall (ASA24): a resource for researchers, clinicians, and educators from the National Cancer Institute. J Acad Nutr Diet. 2012 Aug;112(8):1134–7. doi: 10.1016/j.jand.2012.04.016.
    1. Kirkpatrick S, Subar A, Douglass D, Zimmerman T, Thompson F, Kahle Lisa L, George Stephanie M, Dodd Kevin W, Potischman Nancy. Performance of the Automated Self-Administered 24-hour Recall relative to a measure of true intakes and to an interviewer-administered 24-h recall. Am J Clin Nutr. 2014 Jul;100(1):233–40. doi: 10.3945/ajcn.114.083238.
    1. Park Y, Dodd K, Kipnis V, Thompson F, Potischman N, Schoeller Dale A, Baer David J, Midthune Douglas, Troiano Richard P, Bowles Heather, Subar Amy F. Comparison of self-reported dietary intakes from the Automated Self-Administered 24-h recall, 4-d food records, and food-frequency questionnaires against recovery biomarkers. Am J Clin Nutr. 2018 Jan 01;107(1):80–93. doi: 10.1093/ajcn/nqx002.
    1. Buysse D, Reynolds C, Monk T, Berman S, Kupfer D. The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Research. 1989 May;28(2):193–213. doi: 10.1016/0165-1781(89)90047-4.
    1. Epel E, Tomiyama A, Mason A, Laraia B, Hartman W, Ready KTREDSASIORE, Acree Michael, Adam Tanja C, St Jeor Sachiko, Kessler David. The reward-based eating drive scale: a self-report index of reward-based eating. PLoS One. 2014;9(6):e101350. doi: 10.1371/journal.pone.0101350.
    1. Godin G, Shephard R. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci Internet. 1985:141–6.
    1. de Souza Russell J, Bray G, Carey V, Hall K, LeBoff M, Loria Catherine M, Laranjo Nancy M, Sacks Frank M, Smith Steven R. Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: results from the POUNDS LOST trial. Am J Clin Nutr. 2012 Mar;95(3):614–25. doi: 10.3945/ajcn.111.026328.
    1. Tabachnik B, Fidell L. Using multivariate statistics (5th ed) Boston: MA: Pearson; 2007.
    1. Hartman A, Vining E. Clinical aspects of the ketogenic diet. Epilepsia. 2007 Jan;48(1):31–42. doi: 10.1111/j.1528-1167.2007.00914.x. doi: 10.1111/j.1528-1167.2007.00914.x.
    1. Bostock E, Kirkby K, Taylor BV, Hawrelak Jason A. Consumer Reports of "Keto Flu" Associated With the Ketogenic Diet. Front Nutr. 2020;7:20. doi: 10.3389/fnut.2020.00020. doi: 10.3389/fnut.2020.00020.
    1. Sackner-Bernstein J, Kanter D, Kaul S. Dietary Intervention for Overweight and Obese Adults: Comparison of Low-Carbohydrate and Low-Fat Diets. A Meta-Analysis. PLoS One. 2015;10(10):e0139817. doi: 10.1371/journal.pone.0139817.
    1. Yancy W, Olsen M, Guyton J, Bakst R, Westman E. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern Med. 2004 May 18;140(10):769–77. doi: 10.7326/0003-4819-140-10-200405180-00006.
    1. Czajkowski S, Powell L, Adler N, Naar-King S, Reynolds K, Hunter Christine M, Laraia Barbara, Olster Deborah H, Perna Frank M, Peterson Janey C, Epel Elissa, Boyington Josephine E, Charlson Mary E. From ideas to efficacy: The ORBIT model for developing behavioral treatments for chronic diseases. Health Psychol. 2015 Oct;34(10):971–82. doi: 10.1037/hea0000161.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe